Multi-state cannabis operator MariMed, Inc. MRMD will report its fourth quarter and full year 2021 financial results for the period ending December 31, 2021 on March 16, 2022 after market close. Management will host a conference call on March 17, 2022 at 8:00 a.m. ET to discuss the results.
A webcast will be available and can be accessed via MariMed's investor relations website. To listen to the live call, please visit the website at least 15 minutes early to register, download and install any necessary audio software. A playback of the call will be archived on MariMed's website for approximately 30 days.
MariMed develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. Proprietary formulations created by the company's technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature's Heritage, Bubby's Baked, k FUSION, and Kalm FUSION.
Price Action
MariMed shares traded 0.03% higher at $0.8170 per share at the time of writing Tuesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.